|
SNDX Syndax Pharmaceuticals Inc 1395937 |
| Balance Sheet |
|
Current Assets
|
603,057,000 |
|
Assets
|
724,816,000 |
|
Current Liabilities
|
103,549,000 |
|
Liabilities
|
436,692,000 |
|
Equity
|
288,124,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-274,903,000 |
|
Investing Cash Flow
|
-219,775,000 |
| Market Analysis |
|
Price
|
13.73 |
|
BVPS
|
7.71 |
|
PB
|
1.68 |
|
PS
|
0.39 |
|
FCF
|
-494,678,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/27 |
-1.00 |
3/3 |
-3.72 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SNDX documents filed with the SEC.
SNDX Filings
Clear
